Researchers conduct comprehensive review of treatments for depression in cancer patients

June 26, 2014

Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.

Antidepressants are commonly prescribed, but the evidence on their efficacy is mixed. The role of in treating cancer-related has not been rigorously studied. To identify best practice for the treatment of depression in cancer, Dartmouth researchers completed a systematic review and meta-analysis of existing research. The paper was published in General Hospital Psychiatry in June.

The review identified two classes of antidepressants that reduce :

  • An alpha-2-adrenergic receptor antagonist: Mianserin
  • Two selective serotonin reuptake inhibitors: fluoxetine (Prozac) and paroxetine (Paxil)

Available evidence suggests that paroxetine and fluoxetine can improve but may be less well-tolerated.

Miaserin also showed a higher depression response rate compared to placebo, whereas paroxetine and fluoxetine did not. The response rates were low suggesting only modest changes in depressive symptoms.

"All the evidence for alpha-2-andrenergic receptors was based on a single agent, Mianserin," said Natalie Riblet, MD, MPH, lead author of the study, Department of Psychiatry, Geisel School of Medicine. "Unfortunately, the most promising agent, Mianserin, is not available in the US. Given that Mirtazapine is a close pharmacological cousin of Mianserin, there may be clinical benefit to further exploring the role of Mirtazapine in the management of cancer-related depression."

In terms of side effect profiles, Mianserin appeared slightly more tolerable compared to placebo; paroxetine had slightly higher but nonsignificant dropout rate due to side effects compared to placebo; fluoxetine had a significantly higher dropout than placebo, though this finding became non-significant after removing a study outlier.

"Adverse drug interactions are possible between chemotherapy agents and antidepressants," said Riblet. "Specifically tamoxifen, a common chemotherapy agent, may interact with certain antidepressants to increase risk of serious side effects."

The different classes of antidepressants work on different neurotransmitters. The study reported that the alpha-2-andrenergic receptor antagonists show particular promise in cancer patients possibly due to their pharmacological profile, which increases norepinephrine and serotonin. Alpha-2-andrenergic receptor antagonists are less likely to cause common serotonin-related side effects such as headache, agitation, jitteriness, or sexual dysfunction, but may contribute to sedation.

The review included nine randomized trials conducted between 1985 and 2011 with 4,700 eligible records from 1,169 patients from various countries. Overall 83 percent of subjects were female with a mean age of 54 years.

"There is a scarcity of evidence to address the role of antidepressants in cancer-related depression," said Riblet. "Our findings suggest there is a need for high-quality that explore the role of antidepressants in treating cancer-related depression."

Explore further: Supplements and behavioural therapy make safe headway with Parkinson's

Related Stories

Supplements and behavioural therapy make safe headway with Parkinson's

February 11, 2014
In light of the high degree of psychiatric and cognitive symptoms present in Parkinson's disease (PD) sufferers, researchers have reviewed the efficacy of various therapies used to treat depression and anxiety in PD patients.

Antidepressant-suicide link in youths absent in new analysis

February 6, 2012
In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment ...

Antidepressant use in pregnancy may be associated with structural changes in the infant brain

May 20, 2014
(Medical Xpress)—A new study by University of North Carolina at Chapel Hill researchers found that children of depressed mothers treated with a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs) ...

Australian children and adolescents increasingly use psychotropic drugs

June 19, 2014
(Medical Xpress)—More Australians, particularly children and adolescents, are using psychotropic drugs, a University of Sydney study examining prescribing patterns shows.

Antidepressant use during pregnancy may lead to childhood obesity and diabetes

June 21, 2014
Women who take antidepressants during pregnancy may be unknowingly predisposing their infants to type 2 diabetes and obesity later in life, according to new research from McMaster University.

Recommended for you

Researchers pave new path toward preventing obesity

July 24, 2017
People who experience unpredictable childhoods due to issues such as divorce, crime or frequent moves face a higher risk of becoming obese as adults, according to a new study by a Florida State University researcher.

Using money to buy time linked to increased happiness

July 24, 2017
New research is challenging the age-old adage that money can't buy happiness.

Exposure to violence hinders short-term memory, cognitive control

July 24, 2017
Being exposed to and actively remembering violent episodes—even those that happened up to a decade before—hinders short-term memory and cognitive control, according to a study published in the Proceedings of the National ...

Higher cognitive abilities linked to greater risk of stereotyping

July 24, 2017
People with higher cognitive abilities are more likely to learn and apply social stereotypes, finds a new study. The results, stemming from a series of experiments, show that those with higher cognitive abilities also more ...

Psychologists say our 'attachment style' applies to social networks like Facebook

July 24, 2017
A new investigation appearing this week in the Personality and Social Psychology Bulletin suggests a strong association between a person's attachment style—how avoidant or anxious people are in their close relationships—and ...

Neuroticism may postpone death for some

July 24, 2017
Data from a longitudinal study of over 500,000 people in the United Kingdom indicate that having higher levels of the personality trait neuroticism may reduce the risk of death for individuals who report being in fair or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.